Technology Portfolio: Protein Co-delivery - Arteriocyte Research and Development

Focused on Improving Patient Outcomes

Research & Development

Product Pipeline

Company Information

Research Areas Research Collaborations

Pipeline Technology Portfolio

Mission and Core Values Management Team Newsroom Contact Us

Corporate Homepage

Protein Co-delivery

Arteriocyte's development of a novel protein delivery technology via intra-cellular placement is intended to increase the integrated angiogenic signaling in ischemia. The result is anticipated to be a synergistic angiogenic response without the challenges of unregulated growth signaling. The company's protein co-delivery technology is currently in pre-clinical development.

Arteriocyte, Inc.

Locations:

  Ohio Offices
  Cleveland
  Research & Development Center
  11000 Cedar Avenue
  Suite 270
  Cleveland, Ohio 44106, USA
  Phone: 216-658-3970

  Massachusetts Offices
  Hopkinton
  Eastern US Manufacturing
  and Distribution Center
  45 South Street
  Hopkinton, MA 01748, USA
  Phone: 508-497-8950

  Utah Offices
  Salt Lake City
  Tissue Engineering Center
  6440 South Wasatch Boulevard
  Salt Lake City, UT 84121, USA
  Phone: 866-660-2674

  Texas Offices
  Fort Worth
  Orthopedic Trauma Repair Center
  3400 Camp Bowie Boulevard
  Suite 212
  Fort Worth, TX 76107, USA
  Phone: 866-660-2674

  Maryland Offices
  Towson
  Malaria Initiative Center
  400 East Joppa Road
  Suite 416
  Towson, MD 21286, USA
  Phone: 866-660-2674

  E-mail: info@arteriocyte.com
  Phone: 1-866-660-AMSI(2674)
  Fax: (216) 721-1215